Evome Medical Technologies Inc.
LNDZF
$0.0112
-$0.0488-81.33%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -842.70K | -1.67M | -3.18M | -11.62M | 2.23M |
| Total Depreciation and Amortization | -482.30K | 596.90K | 752.90K | 920.10K | 883.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.12M | 3.69M | 557.60K | 10.66M | -2.65M |
| Change in Net Operating Assets | 1.51M | -332.50K | 1.41M | 853.60K | -541.90K |
| Cash from Operations | 1.31M | 2.28M | -454.00K | 814.20K | -78.90K |
| Capital Expenditure | -15.80K | 0.00 | -28.50K | 17.60K | -68.20K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 0.00 | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -15.80K | 0.00 | -28.50K | 17.60K | -68.20K |
| Total Debt Issued | 1.06M | 121.60K | -- | -1.38M | -804.40K |
| Total Debt Repaid | -2.73M | -2.73M | -255.00K | -158.50K | 824.10K |
| Issuance of Common Stock | -- | -- | -- | 0.00 | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1.22M | -1.91M | -189.20K | -1.13M | 14.70K |
| Foreign Exchange rate Adjustments | 177.80K | 240.20K | 162.50K | 203.70K | -125.10K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 248.80K | 615.10K | -509.20K | -98.50K | -257.60K |
